These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 377731)

  • 1. GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in the canine model and application to clinical bone marrow transplantation.
    Rodt H; Kolb HJ; Netzel B; Rieder I; Janka G; Belohradsky B; Haas RJ; Thierfelder S
    Transplant Proc; 1979 Mar; 11(1):962-6. PubMed ID: 377731
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation in DLA-haploidentical canine littermates: fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG).
    Kolb HJ; Bodenberger U; Rodt HV; Rieder I; Netzel B; Grosse-Wilde H; Scholz S; Thierfelder S
    Haematol Blood Transfus; 1980; 25():61-71. PubMed ID: 7021361
    [No Abstract]   [Full Text] [Related]  

  • 5. Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
    Buckner CD; Clift RA; Fefer A; Lerner KG; Neiman PE; Storb R; Thomas ED
    Transplant Proc; 1974 Dec; 6(4):365-6. PubMed ID: 4612892
    [No Abstract]   [Full Text] [Related]  

  • 6. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of suppressor cells in transplantation tolerance.
    Tutschka PJ; Santos GW; Beschorner W
    Transplant Proc; 1979 Mar; 11(1):882-6. PubMed ID: 156436
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of immune reactions by antilymphocyte serum.
    Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1978 Mar; 10(1):23-9. PubMed ID: 24907
    [No Abstract]   [Full Text] [Related]  

  • 10. New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation.
    Slavin S; Or R; Naparstek E; Cividalli G; Weshler Z; Weiss L; Mumcuoglu M; Engelhard D; Aker M; Pollack A
    Isr J Med Sci; 1986; 22(3-4):264-7. PubMed ID: 3528046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
    Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
    Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone-marrow transplantation in France, 1958-1973.
    Mathé G; Schwarzenberg L
    Transplant Proc; 1974 Dec; 6(4):335-43. PubMed ID: 4155150
    [No Abstract]   [Full Text] [Related]  

  • 15. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation.
    Sykes M; Bukhari Z; Sachs DH
    Bone Marrow Transplant; 1989 Sep; 4(5):465-74. PubMed ID: 2790325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.
    Sykes M; Chester CH; Sundt TM; Romick ML; Hoyles KA; Sachs DH
    J Immunol; 1989 Dec; 143(11):3503-11. PubMed ID: 2584703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD.
    Sykes M; Sheard M; Sachs DH
    J Immunol; 1988 Oct; 141(7):2282-8. PubMed ID: 3049804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts.
    Weiden PL; Doney K; Storb R; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):213-6. PubMed ID: 345561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.